Abstract
Systemic chemotherapy has been increasingly used in the primary treatment of intracranial germinoma. However, the recurrence rate seems to be very high after treatment with chemotherapy alone. We used radiation to treat 5 patients harboring intracranial germinoma that recurred following primary chemotherapy. They had received systemic chemotherapy (4 with cisplatin plus etoposide and 1 with adriamycin, vincristine, cyclophosphamide, prednisolone, and cisplatin) 7–24 months before referral. All patients were treated with conventional radiotherapy directed to the primary tumor site or the craniospinal axis with a dose to the primary site ranging from 39.6 to 47.0 Gy (mean, 42.6 Gy). Response to radiation of all the recurrent tumors was good and all tumors disappeared on diagnostic imaging below the dose of 24 Gy. All patients are alive without further recurrence at 61–129 months after salvage radiotherapy. Germinomas recurring after primary chemotherapy do not seem to have acquired cross resistance to radiotherapy. They can usually be cured by standard radiation therapy with 40–47 Gy.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Shibamoto Y, Takahashi M, Abe M: Reduction of the radiation dose for intracranial germinoma: a prospective study. Br J Cancer 70: 984-989, 1994
Huh SJ, Shin KH, Kim IH, Ahn YC, HaSW, Park CI: Radiotherapy of intracranial germinomas. Radiother Oncol 38: 19-23, 1996
Haddock MG, Schild SE, Scheithauer BW, Schomberg PJ: Radiation therapy for histologically confirmed primary central nervous system germinoma. Int J Radiat Oncol Biol Phys 38: 915-923, 1997
Hardenbergh PH, Golden J, Billet A, Scott RM, Shrieve DC, Silver B, Loeffler JS, Tarbell NJ: Intracranial germinoma: the case for lower dose radiation therapy. Int J Radiat Oncol Biol Phys 39: 419-426, 1997
Shirato H, Nishio M, Sawamura Y, Myohjin M, Kitahara T, Nishioka T, Mizutani Y, Abe H, Miyasaka K: Analysis of long-term treatment of intracranial germinoma. Int J Radiat Oncol Biol Phys 37: 511-515, 1997
Aoyama H, Shirato H, Kakuto Y, Inakoshi H, Nishio M, Yoshida H, Hareyama M, Yanagisawa T, Watarai J, Miyasaka K: Pathologically-proven intracranial germinoma treated with radiation therapy. Radiother Oncol 47: 201-205 1998
Neuwelt EA, Williams PC, Mickey BE, Frenkel EP, Henner WD: Therapeutic dilemma of disseminated CNS germinoma and the potential of increased platinum-based chemotherapy delivery with osmotic blood-brain barrier disruption. Pediatr Neurosurg 21: 16-22, 1994
Balmaceda C, Heller G, Rosenblum M, Diez B, Villablanca JG, Kellie S, Maher P, Vlamis V, Walker RW, Leibel S, Finlay JL: Chemotherapy without irradiation - a novel approach for newly diagnosed CNS germ cell tumors: results of an international cooperative trial. J Clin Oncol 14: 2908-2915, 1996
Allen JC, DaRosso RC, Donahue B, Nirenberg A: Aphase II trial of preirradiation carboplatin in newly diagnosed germinoma of the central nervous system. Cancer 74: 940-944, 1994
Baranzelli MC, Patte C, Bouffet E, Couanet D, Habrand JL, Portas M, Lejars O, Lutz P, Le Gall E, Kalifa C: Nonmetastatic intracranial germinoma. The experience of the French Society of Pediatric Oncology. Cancer 80: 1792-1797, 1997
Matsutani M, Ushio Y, Abe H, Yamashita J, Shibui S, Fujimaki T, Takakura K, Nomura K, Tanaka R, Fukui M, Yoshimoto T, Hayakawa T, Nagashima T, Kurisu K, Kayama T, The Japanese Pediatric Brain Tumor Study Group: Combined chemotherapy and radiation therapy for central nervous system germ cell tumors: preliminary results of a phase II study of the Japanese Pediatric Brain Tumor Study Group. Neurosurg Focus 5(1): Article 7, 1998
Sawamura Y, Shirato H, Ikeda J, Tada M, Ishii N, Kato T, Abe H, Fujieda K: Induction chemotherapy followed by reduced-volume radiation therapy for newly diagnosed central nervous system germinoma. J Neurosurg 88: 66-72, 1998
Shibamoto Y, Takahashi M, Sasai K: Prognosis of intracranial germinoma with syncytiotrophoblastic giant cells treated by radiation therapy. Int J Radiat Oncol Biol Phys 37: 505-510, 1997
ShibamotoY, Abe M, Yamashita J, Takahashi M, Hiraoka M, Ono K, Tsutsui K: Treatment results of intracranial germinoma as a function of the irradiated volume. Int J Radiat Oncol Biol Phys 15: 285-290, 1988
Ott RJ, Brada M, Flower MA, Babich JW, Cherry SR, Deehan BJ: Measurements of blood-brain barrier permeability in patients undergoing radiotherapy and chemotherapy for primary cerebral lymphoma. Eur J Cancer 27: 1356-1361, 1991
Merchant TE, Davis BJ, Sheldon JM, Leibel SA: Radiation therapy for relapsed CNS germinoma after primary chemotherapy. J Clin Oncol 16: 204-209, 1998
Matsutani M: Indication of radiation therapy for intracranial germ cell tumors. Multiinstitutional phase II study. (Abstract in Japanese) J Jpn Soc Ther Radiol Oncol 10 (Suppl 1): 98, 1998
Regine WF, Hodes JE, Patchell RA: Intracranial germinoma: treatment with radiosurgery alone - a case report. J Neuro Oncol 37: 75-77, 1998
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Shibamoto, Y., Sasai, K., Kokubo, M. et al. Salvage Radiation Therapy for Intracranial Germinoma Recurring After Primary Chemotherapy. J Neurooncol 44, 181–185 (1999). https://doi.org/10.1023/A:1006367316168
Issue Date:
DOI: https://doi.org/10.1023/A:1006367316168